老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Benitec Biopharma Limited

8.63
-0.4400-4.85%
盘后：8.630.00000.00%19:30 EDT
成交量：15.14万
成交额：131.40万
市值：3.01亿
市盈率：-8.82
高：9.08
开：9.08
低：8.51
收：9.07
52周最高：16.76
52周最低：8.51
股本：3,488.27万
流通股本：1,845.34万
量比：0.83
换手率：0.82%
股息：- -
股息率：- -
每股收益(TTM):-0.9783
每股收益(LYR):-0.9800
净资产收益率：-33.21%
总资产收益率：-22.67%
市净率：1.70
市盈率(LYR):-8.81

数据加载中...

总览公司新闻资讯公告
2020/03/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/23

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/12/12

SEC问询函

[Cover]Correspondence
2019/12/09

招股说明书

Registration statement for certain foreign private issuers
2019/12/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/30

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/10/08

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/10/07

超过5%披露

Statement of acquisition of beneficial ownership by individuals
更多